Inhibition of Glycolysis in Pathogenic TH17 Cells through Targeting a miR-21–Peli1–c-Rel Pathway Prevents Autoimmunity

Rong Qiu1,2; Xiang Yu1; Li Wang1; Zhijun Han3; Chao Yao2; Yange Cui2; Guojun Hou1; Dai Dai1; Wenfei Jin3; Nan Shen1,4

2020-05-15

The Journal of Immunology   影响因子和分区

SCI

英语

其他

1.Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China.
2.Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200001, China.
3.Department of Biology, Southern University of Science and Technology, Shenzhen 518000, China.
4.Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China; nanshensibs@gmail.com.
5.Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China.
6.Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200001, China.
7.Department of Biology, Southern University of Science and Technology, Shenzhen 518000, China.
8.Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China; nanshensibs@gmail.com.

Rong Qiu,Xiang Yu,Li Wang,等. Inhibition of Glycolysis in Pathogenic TH17 Cells through Targeting a miR-21–Peli1–c-Rel Pathway Prevents Autoimmunity[J]. The Journal of Immunology,2020.

Rong Qiu.,Xiang Yu.,Li Wang.,Zhijun Han.,Chao Yao.,...&Nan Shen.(2020).Inhibition of Glycolysis in Pathogenic TH17 Cells through Targeting a miR-21–Peli1–c-Rel Pathway Prevents Autoimmunity.The Journal of Immunology.

Rong Qiu,et al."Inhibition of Glycolysis in Pathogenic TH17 Cells through Targeting a miR-21–Peli1–c-Rel Pathway Prevents Autoimmunity".The Journal of Immunology (2020).